SONJCPFA
CLDX icon

State of New Jersey Common Pension Fund A’s Celldex Therapeutics CLDX Stock Holding History

State of New Jersey Common Pension Fund A’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$7.25M Hold
27,333
– – 0.03% 426
2013
Q4 		$9.93M Sell
27,333
-5,000
-15% -$1.93M 0.05% 366
2013
Q3 		$17.2M Sell
32,333
-3,000
-8% -$1.03M 0.08% 283
2013
Q2 		$8.27M Buy
+35,333
New +$6.96M 0.04% 417

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State of New Jersey Common Pension Fund A's CLDX Position: Q1 2014 in Review

State of New Jersey Common Pension Fund A held its Celldex Therapeutics (CLDX) position steady in Q1 2014 at 27,333 shares worth $7.25M. The position accounts for 0.03% of the portfolio, ranked #426.

State of New Jersey Common Pension Fund A first reported a position in CLDX in Q2 2013 and has held it in 4 quarters since. The position peaked at $17.2M in Q3 2013. 157 funds tracked by Wall St. Rank hold CLDX as of Q1 2014.

  • State of New Jersey Common Pension Fund A held 27,333 shares of Celldex Therapeutics worth $7.25M as of Q1 2014.
  • State of New Jersey Common Pension Fund A left its Celldex Therapeutics share count unchanged in Q1 2014.
  • Celldex Therapeutics made up 0.03% of State of New Jersey Common Pension Fund A's portfolio in Q1 2014, its #426 holding.
  • State of New Jersey Common Pension Fund A first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 4 quarters since.
  • State of New Jersey Common Pension Fund A's Celldex Therapeutics position peaked at $17.2M in Q3 2013.
  • 157 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2014.

Based on State of New Jersey Common Pension Fund A's 13F filing for Q1 2014, filed 5 May 2014.